<DOC>
	<DOCNO>NCT02904603</DOCNO>
	<brief_summary>Direct act antiviral offer new opportunity monitor immune response Hepatitis C infection . In study cytokine marker measure therapy time point SVR 12 correlate clinical Parameters regular laboratory finding .</brief_summary>
	<brief_title>Immune Monitoring Hepatitis C Under DAA Therapy</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>write consent , age , HCVRNA positive , DAA therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>